Literature DB >> 22582125

An In Vitro Diagnostic Multivariate Index Assay (IVDMIA) for Ovarian Cancer: Harvesting the Power of Multiple Biomarkers.

Zhen Zhang1.   

Abstract

In this review, OVA1® (Vermillion, Inc., Austin, TX), the first in vitro diagnostic multivariate index assay (IVDMIA) of protein biomarkers cleared by the US Food and Drug Administration (FDA), is used to explain the concept behind IVDMIA, the use of multiple markers to improve clinical performance of a diagnostic tool, and the key considerations in the development of IVDMIA.

Entities:  

Keywords:  CA-125; In vitro diagnostic multivariate index assay; Ovarian cancer; Protein biomarkers

Year:  2012        PMID： 22582125      PMCID： PMC3349922     

Source DB:  PubMed          Journal:  Rev Obstet Gynecol        ISSN： 1941-2797


  21 in total

1.  Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma.

Authors:  Mirjam J A Engelen; Henrike E Kos; Pax H B Willemse; Jan G Aalders; Elisabeth G E de Vries; Michael Schaapveld; Renee Otter; Ate G J van der Zee
Journal:  Cancer       Date:  2006-02-01       Impact factor: 6.860

Review 2.  Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer care.

Authors:  B E Hillner; T J Smith; C E Desch
Journal:  J Clin Oncol       Date:  2000-06       Impact factor: 44.544

3.  Committee Opinion No. 477: the role of the obstetrician-gynecologist in the early detection of epithelial ovarian cancer.

Authors: 
Journal:  Obstet Gynecol       Date:  2011-03       Impact factor: 7.661

4.  Effectiveness of a multivariate index assay in the preoperative assessment of ovarian tumors.

Authors:  Frederick R Ueland; Christopher P Desimone; Leigh G Seamon; Rachel A Miller; Scott Goodrich; Iwona Podzielinski; Lori Sokoll; Alan Smith; John R van Nagell; Zhen Zhang
Journal:  Obstet Gynecol       Date:  2011-06       Impact factor: 7.661

5.  Proteomic approaches to tumor marker discovery.

Authors:  Alex J Rai; Zhen Zhang; Jason Rosenzweig; Ie-Ming Shih; Thang Pham; Eric T Fung; Lori J Sokoll; Daniel W Chan
Journal:  Arch Pathol Lab Med       Date:  2002-12       Impact factor: 5.534

6.  Use of proteomic patterns in serum to identify ovarian cancer.

Authors:  Emanuel F Petricoin; Ali M Ardekani; Ben A Hitt; Peter J Levine; Vincent A Fusaro; Seth M Steinberg; Gordon B Mills; Charles Simone; David A Fishman; Elise C Kohn; Lance A Liotta
Journal:  Lancet       Date:  2002-02-16       Impact factor: 79.321

7.  Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients.

Authors:  Craig C Earle; Deborah Schrag; Bridget A Neville; K Robin Yabroff; Marie Topor; Angela Fahey; Edward L Trimble; Diane C Bodurka; Robert E Bristow; Michael Carney; Joan L Warren
Journal:  J Natl Cancer Inst       Date:  2006-02-01       Impact factor: 13.506

8.  Initial evaluation and referral guidelines for management of pelvic/ovarian masses.

Authors:  Tien Le; Christopher Giede; Shia Salem; Guylaine Lefebvre; Barry Rosen; James Bentley; Rachel Kupets; Patti Power; Marie-Claude Renaud; Peter Bryson; Donald B Davis; Susie Lau; Robert Lotocki; Vyta Senikas; Lucie Morin; Stephen Bly; Kimberly Butt; Yvonne M Cargill; Nanette Denis; Robert Gagnon; Marja Anne Hietala-Coyle; Kenneth Ian Lim; Annie Ouellet; Maria-Hélène Raciot
Journal:  J Obstet Gynaecol Can       Date:  2009-07

9.  Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening.

Authors:  W J Catalona; D S Smith; R L Wolfert; T J Wang; H G Rittenhouse; T L Ratliff; R B Nadler
Journal:  JAMA       Date:  1995-10-18       Impact factor: 56.272

10.  Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: potential use in diagnosis and prognosis.

Authors:  Katherine R Kozak; Malaika W Amneus; Suzanne M Pusey; Feng Su; Mui N Luong; Sam A Luong; Srinivasa T Reddy; Robin Farias-Eisner
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-01       Impact factor: 11.205
View more
  22 in total

Review 1.  Current application of proteomics in biomarker discovery for inflammatory bowel disease.

Authors:  Patrick Py Chan; Valerie C Wasinger; Rupert W Leong
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

2.  Identification of Mycobacterial Antigens in Human Urine by Use of Immunoglobulin G Isolated from Sera of Patients with Active Pulmonary Tuberculosis.

Authors:  Sun Hee Kim; Nan-Ee Lee; Jong Seok Lee; Jeong Hwan Shin; Ju Yeon Lee; Jeong-Heon Ko; Chulhun Ludgerus Chang; Yong-Sam Kim
Journal:  J Clin Microbiol       Date:  2016-03-16       Impact factor: 5.948

3.  Semi-quantitative measurement of a specific glycoform using a DNA-tagged antibody and lectin affinity chromatography for glyco-biomarker development.

Authors:  Ju Hee Lee; Chang Hee Cho; Sun Hee Kim; Jeong Gu Kang; Jong Shin Yoo; Chulhun Ludgerus Chang; Jeong-Heon Ko; Yong-Sam Kim
Journal:  Mol Cell Proteomics       Date:  2014-12-18       Impact factor: 5.911

Review 4.  Biomarkers in reproductive medicine: the promise, and can it be fulfilled?

Authors:  Stephen S Palmer; Kurt T Barnhart
Journal:  Fertil Steril       Date:  2012-12-14       Impact factor: 7.329

Review 5.  Biomarkers in uterine leiomyoma.

Authors:  Gary Levy; Micah J Hill; Torie C Plowden; William H Catherino; Alicia Y Armstrong
Journal:  Fertil Steril       Date:  2012-11-29       Impact factor: 7.329

6.  Identification of Serum Biomarker Panels for the Early Detection of Pancreatic Cancer.

Authors:  Jin Song; Lori J Sokoll; Jered J Pasay; Abigail L Rubin; Hanying Li; Dylan M Bach; Daniel W Chan; Zhen Zhang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-10-17       Impact factor: 4.254

7.  Challenges and opportunities for translating medical microdevices: insights from the programmable bio-nano-chip.

Authors:  Michael P McRae; Glennon Simmons; John T McDevitt
Journal:  Bioanalysis       Date:  2016-04-13       Impact factor: 2.681

8.  Proteomic cancer biomarkers from discovery to approval: it's worth the effort.

Authors:  Danni Li; Daniel W Chan
Journal:  Expert Rev Proteomics       Date:  2014-04       Impact factor: 3.940

9.  The sbv IMPROVER Systems Toxicology Computational Challenge: Identification of Human and Species-Independent Blood Response Markers as Predictors of Smoking Exposure and Cessation Status.

Authors:  Vincenzo Belcastro; Carine Poussin; Yang Xiang; Maurizio Giordano; Kumar Parijat Tripathi; Akash Boda; Stéphanie Boué; Mario Guarracino; Florian Martin; Manuel C Peitsch; Julia Hoeng; Roberto Romero; Adi L Tarca; Zhongqu Duan; Hao Yang; Xiaofeng Gong; Peixuan Wang; Chenfang Zhang; Wenxin Yang; Omer Sinan Sarac; Ismail Bilgen; Ali Tugrul Balci; Rahul Kumar; Sandeep Kumar Dhanda
Journal:  Comput Toxicol       Date:  2017-07-14

Review 10.  Comprehending the Proteomic Landscape of Ovarian Cancer: A Road to the Discovery of Disease Biomarkers.

Authors:  Shuvolina Mukherjee; Karin Sundfeldt; Carl A K Borrebaeck; Magnus E Jakobsson
Journal:  Proteomes       Date:  2021-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.